Basel, France

Lorenz Urner

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lorenz Urner. Retrieved from https://idiyas.com/inventor/lorenz-urner-tokx6ys9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lorenz Urner: Innovator in Antibacterial Compounds

Introduction

Lorenz Urner is a notable inventor based in Basel, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. His work focuses on creating novel compounds that can effectively combat bacterial infections.

Latest Patents

Urner holds a patent for "Imidazole-pyrazole derivatives as antibacterials." This invention provides novel imidazole pyrazole derivatives characterized by a specific general formula. The patent also includes pharmaceutically acceptable salts of these compounds. Furthermore, it outlines pharmaceutical compositions that incorporate these compounds, along with processes for manufacturing them. The methods described in the patent highlight the use of these compounds as medicaments, specifically as antibiotics for the treatment or prevention of bacterial infections and related diseases.

Career Highlights

Lorenz Urner is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has been instrumental in advancing research and development in antibacterial therapies.

Collaborations

Urner collaborates with Sandra Marie Joseph Ulsemer, contributing to the innovative research environment at Hoffmann-La Roche Inc.

Conclusion

Lorenz Urner's contributions to the field of antibacterial compounds demonstrate his commitment to improving healthcare through innovation. His patent on imidazole-pyrazole derivatives showcases the potential for new treatments in combating bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…